# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-002822
Filing Date
2025-04-04
Accepted
2025-04-04 17:17:58
Documents
20
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm iXBRL | PRE 14A | 707962
2 |  | formpre14a_001.jpg | GRAPHIC | 53136
3 |  | formpre14a_002.jpg | GRAPHIC | 51761
4 |  | proxy_001.jpg | GRAPHIC | 365319
5 |  | proxy_002.jpg | GRAPHIC | 298797
| Complete submission text file | 0001641172-25-002822.txt |  | 3217883

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | envb-20241231.xsd | EX-101.SCH | 5338
7 | XBRL DEFINITION FILE | envb-20241231_def.xml | EX-101.DEF | 9644
8 | XBRL LABEL FILE | envb-20241231_lab.xml | EX-101.LAB | 62495
9 | XBRL PRESENTATION FILE | envb-20241231_pre.xml | EX-101.PRE | 44314
22 | EXTRACTED XBRL INSTANCE DOCUMENT | formpre14a_htm.xml | XML | 88304

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38286 | Film No.: 25815798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)